# PREventing Progression of Adipose Tissue Redistribution

> **NCT00389194** · PHASE4 · COMPLETED · sponsor: **International Antiviral Therapy Evaluation Center** · enrollment: 120 (estimated)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** continuing AZT+3TC or switching AZT+3TC to TDF+ FTC

## Key facts

- **NCT ID:** NCT00389194
- **Lead sponsor:** International Antiviral Therapy Evaluation Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** —
- **Final completion:** 2008-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389194, "PREventing Progression of Adipose Tissue Redistribution". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00389194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*